Microbot Medical® Liberty®血管介入机器人系统获多地区采用 涵盖两个ACCESS-PVI关键临床试验基地

美股速递
May 05

Microbot Medical Inc旗下Liberty®血管介入机器人系统目前已在多个重点区域获得临床应用,其中包括两个参与ACCESS-PVI关键临床试验的医疗中心。该系统的推广部署标志着血管介入手术机器人技术迈向更广泛的临床验证阶段。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10